360 Financial’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$265K Buy
288
+3
+1% +$3.04K 0.08% 62
2025
Q4
$306K Buy
285
+6
+2% +$5.74K 0.09% 61
2025
Q3
$213K Buy
+279
New +$208K 0.07% 79

Other funds holding LLY

360 Financial's LLY Position: Q1 2026 in Review

360 Financial increased its Eli Lilly (LLY) stake by 1.1% in Q1 2026, buying an estimated $3.04K and bringing the position to 288 shares worth $265K. The position accounts for 0.08% of the portfolio, ranked #62.

360 Financial first reported a position in LLY in Q3 2025 and has held it in 3 quarters since. The position peaked at $306K in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • 360 Financial held 288 shares of Eli Lilly worth $265K as of Q1 2026.
  • 360 Financial bought 3 Eli Lilly shares in Q1 2026, an estimated $3.04K.
  • Eli Lilly made up 0.08% of 360 Financial's portfolio in Q1 2026, its #62 holding.
  • 360 Financial first reported a position in Eli Lilly in Q3 2025 and has held it in 3 quarters since.
  • 360 Financial's Eli Lilly position peaked at $306K in Q4 2025.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on 360 Financial's 13F filing for Q1 2026, filed 7 May 2026.